Drug intelligence / Profile preview

MDMA analog

Development stage
Preclinical
Lead developer
EQUULUS Therapeutics
Modality
Small Molecules
Administration
Oral, Sublingual, Intranasal, Intravenous, Subcutaneous
01

Overview

MDMA analog is a small molecule serotonin (5-HT) releaser being developed by EQUULUS Therapeutics for the treatment of post-traumatic stress disorder (PTSD). As a psychedelic-inspired therapeutic, it is designed to be non-dissociative and empathy-enhancing, aiming to provide the prosocial and emotional processing benefits of MDMA without the associated neurotoxicity or euphoric effects. The compound is currently in the discovery stage of development and represents a key asset in EQUULUS's mission to develop mainstream CNS therapeutics that address the root causes of psychiatric conditions.

Other names
3,4-methylenedioxymethamphetamine analog
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)5-HT2 (5-HT2 receptor family)

Beyond the preview

Go deeper on MDMA analog.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDMA analog.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call